HIGHLIGHTS
- who: AXL and collaborators from the Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital have published the research: Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway, in the Journal: (JOURNAL) of 11/01/2022
- what: | membranes were washed for 3 10 min in TBS/T (20 mM Tris-HCl pH 7.5, 137 mM NaCl, and 0.1% tween20).
SUMMARY
Increased transcriptional levels of SOX10 are Correlations in melanoma cell lines suggested to desensitize BRAF-mutant melanoma to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.